More efficacious disease-modifying treatment is likely the main reason for a trend to slower progression in relapsing onset multiple sclerosis (ROMS), researchers say. A Swedish study of more than 7,000 patients with follow-up of about 8.5 years has found those diagnosed in more recent times took longer to reach disability milestones. It found a 3% ...
Better drugs explain why MS progression appears to be slowing
By Mardi Chapman
28 Mar 2019